Detalhe da pesquisa
1.
ANCHOR: melflufen plus dexamethasone and daratumumab or bortezomib in relapsed/refractory multiple myeloma: final results of a phase I/IIa study.
Haematologica
; 109(3): 867-876, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37646657
2.
Efficacy and safety of melflufen plus daratumumab and dexamethasone in relapsed/refractory multiple myeloma: results from the randomized, open-label, phase III LIGHTHOUSE study.
Haematologica
; 109(3): 895-905, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37646660
3.
Health-related quality of life in relapsed/refractory multiple myeloma treated with melflufen and dexamethasone: analyses from the phase III OCEAN study.
Haematologica
; 2024 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38426292
4.
Melflufen in relapsed/refractory multiple myeloma refractory to prior alkylators: A subgroup analysis from the OCEAN study.
Eur J Haematol
; 112(3): 402-411, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37968873
5.
Patient-reported outcomes in relapsed/refractory multiple myeloma treated with melflufen plus dexamethasone: analyses from the Phase II HORIZON study.
Br J Haematol
; 196(3): 639-648, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34671975
6.
Impact of Treatment Delay on Outcome in the International Subarachnoid Aneurysm Trial.
Stroke
; 51(5): 1600-1603, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32208844
7.
Prediction of Outcome After Aneurysmal Subarachnoid Hemorrhage.
Stroke
; 50(4): 837-844, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30869562
8.
ASTRIS: a global real-world study of osimertinib in >3000 patients with EGFR T790M positive non-small-cell lung cancer.
Future Oncol
; 15(26): 3003-3014, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31339357
9.
Predictive Factors for Rebleeding After Aneurysmal Subarachnoid Hemorrhage: Rebleeding Aneurysmal Subarachnoid Hemorrhage Study.
Stroke
; 46(8): 2100-6, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26069261
10.
Feasibility of immediate placement of single-tooth implants in the aesthetic zone: a 1-year randomized controlled trial.
J Clin Periodontol
; 42(8): 773-782, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26119346
11.
Appreciation of CT-negative, lumbar puncture-positive subarachnoid haemorrhage: risk factors for presence of aneurysms and diagnostic yield of imaging.
J Neurol Neurosurg Psychiatry
; 85(8): 885-8, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24357683
12.
PORT: A Randomized, Cross-Over, Phase 2 Study of Melflufen Peripheral Versus Central Intravenous Administration in Patients With Relapsed/Refractory Multiple Myeloma.
Clin Lymphoma Myeloma Leuk
; 2024 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38490927
13.
Benefit Versus Risk Assessment of Melflufen and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Analyses From Longer Follow-up of the OCEAN and HORIZON Studies.
Clin Lymphoma Myeloma Leuk
; 23(9): 687-696, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37355418
14.
Posterior transdural discectomy: a new approach for the removal of a central thoracic disc herniation.
Eur Spine J
; 21(4): 623-8, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21947869
15.
Melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide (OCEAN): a randomised, head-to-head, open-label, phase 3 study.
Lancet Haematol
; 9(2): e98-e110, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35032434
16.
ISAT: end of the debate on coiling versus clipping?
Lancet
; 385(9984): 2251, 2015 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26088494
17.
Melflufen and Dexamethasone in Heavily Pretreated Relapsed and Refractory Multiple Myeloma.
J Clin Oncol
; 39(7): 757-767, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33296242
18.
What Ingredients Have You Used to Prepare This Delicious Lunch? A Critical Look Behind a Meta-analysis.
Ann Surg
; 262(6): e113-4, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24950269
19.
Feasibility of magnetic resonance angiography (MRA) follow-up as the primary imaging modality after coiling of intracranial aneurysms.
Acta Radiol
; 51(2): 226-32, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20088646
20.
Epstein-Barr virus-DNA load monitoring late after lung transplantation: a surrogate marker of the degree of immunosuppression and a safe guide to reduce immunosuppression.
Transplantation
; 83(4): 433-8, 2007 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-17318076